Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 151 No. 4546 (2021)

Swiss interdisciplinary guidance on good practices for acute and complicated diabetic foot syndromes

  • Bettina Peter-Riesch
  • Astrid Czock
  • Ilker Uçkay
DOI
https://doi.org/10.4414/SMW.2021.w30045
Cite this as:
Swiss Med Wkly. 2021;151:w30045
Published
11.11.2021

Summary

BACKGROUND: Diabetic foot syndromes (DFS) usually have negative outcomes for patients characterised by multiple comorbidities and frailty. In Switzerland, we need a nationwide "quality of care" programme consisting of evidence-based, practical guidance for primary care providers, together with the implementation of a multidisciplinary care system for DFS.

METHODS: Elaboration of interprofessional and comprehensive Swiss practical guidance for the timely management of acute DFS. This guidance will not replace existing recommendations, but will be complementary to them. Before nationwide implementation, three Swiss  pilot sites will test the guidance in collaboration with local interprofessional foot-care centres.

RESULTS: Under the umbrella of QualiCCare, and endorsed by the professional societies involved, twenty experts from all relevant professions issued four protocols for various aspects of DFS between March 2018 and January 2020. In addition, they defined criteria for triage and treatment in primary care, as well as the timely referral of patients with DFS to interprofessional foot-care centres. We propose a framework for multidisciplinary, specialised foot-care networks, and interprofessional foot-care centres. The piloting of the proposed concepts is underway. All documents are available on the website www.qualiccare.ch.

CONCLUSIONS: We provide evidence-based tools for Swiss primary care providers and specialists, and increase the accessibility for patients to specialised and timely care of DFS.

References

  1. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America (IDSA) clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):132–73. https://doi.org/10.1093/cid/cis346
  2. Uçkay I, Jornayvaz FR, Lebowitz D, Gastaldi G, Gariani K, Lipsky BA. An Overview on Diabetic Foot Infections, including Issues Related to Associated Pain, Hyperglycemia and Limb Ischemia. Curr Pharm Des. 2018;24(12):1243–54. https://doi.org/10.2174/1381612824666180302145754
  3. Krzywicki CP, Wasserfallen JB. [Hospitalizations due to diabetic foot in Switzerland]. Rev Med Suisse. 2012 Jun;8(344):1215–6.
  4. Peter-Riesch B. The diabetic foot: the never-ending challenge. Endocr Dev. 2016;31:108–34. https://doi.org/10.1159/000439409
  5. Lipsky BA, Senneville E, Abbas ZG, Aragón-Sánchez J, Diggle M, Embil JM, et al. IWGDF guideline on the diagnosis and treatment of foot infection in people with diabetes. Diabetes Metab Res Rev. 2020;36:3280.
  6. Ertuğrul B, Uçkay I, Schöni M, Peter-Riesch B, Lipsky BA. Management of diabetic foot infections in the light of recent literature and new international guidelines. Expert Rev Anti Infect Ther. 2020 Apr;18(4):293–305. https://doi.org/10.1080/14787210.2020.1730177
  7. Valeri F, Hatz C, Jordan D, Leuthold C, Czock A, Lang P. Immunisation coverage of adults: a vaccination counselling campaign in the pharmacies in Switzerland. Swiss Med Wkly. 2014 Apr;144:w13955. https://doi.org/10.4414/smw.2014.13955
  8. Schimke K, Chappuis B, Egli M, Hagon-Traub I, Malacarne S, Schönenweid C, et al. Prévention et prise en charge des problèmes de pieds chez les patients diabétiques. Swiss Medical Forum-Forum Médical Suisse. 2016;16(2829):578–83. https://doi.org/10.4414/fms.2016.02695
  9. Malacarne S, Chappuis B, Egli M, Hagon-Traub I, Schimke K, Schönenweid C, et al. [Preventive measures of diabetic foot complications]. Rev Med Suisse. 2016 Jun;12(521):1092–6.
  10. Hinchliffe RJ, Brownrigg JR, Andros G, Apelqvist J, Boyko EJ, Fitridge R, et al.; International Working Group on the Diabetic Foot. Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review. Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:136–44. https://doi.org/10.1002/dmrr.2705
  11. Vettori A, von Stokar T, Angst V, Diem P. INFRAS. Auswirkungen der Aufnahme von Podologinnen und Podologen als Leistungserbringer zulasten der obligatorischen Krankenpflegevrrsicherung (OKP). INFRAS: 30 November 2018.
  12. Rosskopf AB, Loupatatzis C, Pfirrmann CW, Böni T, Berli MC. The Charcot foot: a pictorial review. Insights Imaging. 2019 Aug;10(1):77. https://doi.org/10.1186/s13244-019-0768-9
  13. Chantelau EA, Richter A. The acute diabetic Charcot foot managed on the basis of magnetic resonance imaging—a review of 71 cases. Swiss Med Wkly. 2013 Jul;143:w13831. https://doi.org/10.4414/smw.2013.13831
  14. Lewis J, Lipp A. Pressure-relieving interventions for treating diabetic foot ulcers. Cochrane Database Syst Rev. 2013 Jan;1(1):CD002302. https://doi.org/10.1002/14651858.CD002302.pub2
  15. Swiss Society for Infectious Diseases. DIGEST-Guideline 2019: Infections du pied diabétique. https://ssi.guidelines.ch/guideline/3056 (last assessed on 4 July 2021). French-language version; also available as a German-language version.
  16. Bundesamt für Gesundheit. Änderung der Verordnung über die Krankenversicherung und der Krankenpflege-Leistungsverordnung. Zulassung der Podologinnen und Podologen als Leistungserbringer im Rahmen der obligatorischen Krankenpflegeversicherung (OKP). https://www.bag.admin.ch/bag/de/home/versicherungen/krankenversicherung/krankenversicherung-revisionsprojekte/aenderungen-zulassung-podologen-als-leistungserbringer.html
  17. Black N, Murphy M, Lamping D, McKee M, Sanderson C, Askham J, et al. Consensus development methods: a review of best practice in creating clinical guidelines. J Health Serv Res Policy. 1999 Oct;4(4):236–48. https://doi.org/10.1177/135581969900400410

Most read articles by the same author(s)